It is noted that in June 2020, it is planned to transfer 60 thousand courses of medication to medical institutions.
“We propose to close the acute need for the drug through an even distribution across all regions. By the middle of next week it is planned to produce Avifavir in the amount necessary to satisfy all applications received to date from 35 regions, ”the Izvestia statement quoted.
Previously, developers noted cases of fraud with the sale of drugs for the treatment of coronavirus based on the active substance favipiravir.